How much is PCI Pharma Services worth?

PCI Pharma Services, a leading global CDMO focused on biopharma's most complex therapies, has invested over $365 million in EU and US facilities for clinical and commercial supply of advanced drug delivery and drug-device combination products. The company also announced a $100 million investment in New Hampshire to expand its sterile liquid filling and lyophilization capabilities. PCI's total worth is not explicitly stated but can be inferred to be substantial based on its significant investments and global presence.